drugset / Trial / NCT03578042

Fixed-Free HTN Trial

NCT03578042

Phase 4 Unknown 100 enrolled Hotel Dieu de France Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Evaluation of the effect of FIXED triple anti-hypertensive therapy with losartan-amlodipin-HCTZ vs any free triple combination therapy chosen by the treating physician for patients with uncontrolled hypertension

Timeline

Start
2017-04-01
Primary completion
2019-09-30
Completion
2019-12-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amlodipine Other / unclassified 5 mg
Comparator Hydrochlorothiazide Unknown 12.5 mg
Comparator Losartan Other / unclassified 100 mg

Indications